Viewing Study NCT04836832


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2026-02-01 @ 4:56 AM
Study NCT ID: NCT04836832
Status: WITHDRAWN
Last Update Posted: 2022-06-07
First Post: 2021-03-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Acalabrutinib and Duvelisib for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Sponsor: Narendranath Epperla
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module